Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 75.48

+1.4%

Nov 14 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2075)	1/4/2008 10:08:20 AM
From: Jibacoa	Read Replies (2) of 3722

OSIR started with an UG & was up 24.19% but is up only 14.5% at present.<g> bigcharts.marketwatch.com It announced yesterday, after the market closed, that it has been awarded a $224.7M contract from the DoD to develop and stockpile Prochymal, an adult stem cell therapy, for repair of gastrointestinal injury from radiation exposure. Of course, the general market isn't helping as it seems we won't have a January Effect this Yr., but with the short ratio around 20x its ADV, on a close above $15 the stock could get to test its March H at $22.30 or even its Jan 2007 H at 29.29 <g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next